# Docquity Holdings PTE

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/docquity-holdings-pte

- Industry: Healthcare IT
- Headquarters: Singapore
- Website: www.docquity.com
- Total disclosed funding: $57M
- Latest round: Series C (Aug 17, 2022)
- Investors on record: 13

## About

Based in Singapore, Docquity Holdings PTE Limited is a digital platform dedicated to enhancing medical education for healthcare professionals across Southeast Asia, facilitating collaboration and knowledge-sharing among medical experts.Docquity Holdings PTE Limited, founded in 2015 in Singapore, operates as a digital platform for healthcare professionals. The company has not undergone significant pivots in its business strategy and remains independent. The founders, Amit Vithal and Indranil Roychowdhury, have prior experience in the digital healthcare sector. As of September 2024, Docquity secured a Series C funding round amounting to USD 43.97 mn led by Itochu, with a total fundraising amount of USD 43.97 mn to date. The company currently holds a valuation of USD 196.97 mn and has completed six notable deals.Docquity is a leading digital platform designed specifically for healthcare professionals, facilitating continuous medical education and professional development across Southeast Asia. The company's core offerings include access to a diverse network of medical experts, educational resources, and interactive content that enhances clinical knowledge and fosters collaboration among healthcare practitioners. Specifically, Docquity provides webinars, recorded sessions, and a database of medical journals, enabling users to earn Continuing Medical Education (CME) and Continuing Professional Development (CPD) credits at their convenience. The platform serves over 410,000 doctors from countries including Indonesia, Malaysia, the Philippines, Thailand, Vietnam, Singapore, and Taiwan, addressing the evolving needs of healthcare providers by ensuring they remain knowledgeable on the latest advancements in their fields.In the year 2023, Docquity reported a revenue of USD 3,916,797.90 and an EBITDA of USD 18,353,740.60, generated through a subscription-based model tailored for healthcare professionals. The company’s revenue streams include individual subscriptions and institutional partnerships, which allow healthcare organizations to enroll multiple users. Additionally, the platform provides monetization opportunities for professionals who contribute educational content, diversifying its revenue base while fostering a collaborative community of healthcare experts.Looking ahead, Docquity plans to enhance its platform with new educational offerings and interactive features aimed at better serving healthcare professionals. The company is exploring expansion into additional Southeast Asian markets to capitalize on the growing demand for digital medical education. The recent Series C funding will support these initiatives, enabling the company to improve its services and infrastructure. Notably, in September 2024, MRT Inc. agreed to acquire a 7.5% minority stake in Docquity Holdings PTE Limited from Itochu Corporation, which will aid in expanding MRT Inc.'s medical recruitment business within the region.

## Funding rounds

- Series C, Aug 17, 2022, $44M — Itochu, iGlobe Partners, Global Brain, Infocomm Development Authority of Singapore, Alkemi Growth Capital, KDV Capital
- Series B, Mar 11, 2019, $11M — Itochu, KDV Capital, SPH Media Fund, Zuellig Pharma Holdings Pte. Ltd.
- Series A, Sep 6, 2018, $2.7M — Spiral Ventures, Convergence Ventures, Purvi Capital, Genesia Ventures, KDV Capital, SPH Media Fund, Zuellig Pharma Holdings Pte. Ltd., PT MORULA INDONESIA

## Investors

- Spiral Ventures (https://capitalatlas.ai/funds/spiral-ventures) — Series A
- Convergence Ventures — Series A
- Purvi Capital (https://capitalatlas.ai/funds/purvi-capital) — Series A
- Genesia Ventures (https://capitalatlas.ai/funds/genesia-ventures) — Series A
- KDV Capital (https://capitalatlas.ai/funds/kdv-capital) — Series A, Series B, Series C
- SPH Media Fund (https://capitalatlas.ai/funds/sph-media-fund) — Series A, Series B
- Zuellig Pharma Holdings Pte. Ltd. — Series A, Series B
- PT MORULA INDONESIA — Series A
- Itochu — Series B, Series C
- iGlobe Partners (https://capitalatlas.ai/funds/iglobe-partners) — Series C
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series C
- Infocomm Development Authority of Singapore — Series C
- Alkemi Growth Capital (https://capitalatlas.ai/funds/alkemi-growth-capital) — Series C